Trial
NCT00748410
Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
GlaxoSmithKline
Collaborators
—
Condition
Colitis, Ulcerative
Intervention
SB-656933
Why stopped
SB-656933 is no longer being developed for ulcerative colitis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-30